Tech Company Financing Transactions

Tessellate BIO Funding Round

Tessellate BIO secured a $8.5 million Seed funding round on 10/17/2023. Investors included BioGeneration Ventures and Forbion Capital Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Gooimer 235
Naarden, 1411 DC
NL

Phone

Undisclosed

Website

www.tessellatebio.com

Email Address

Undisclosed

Overview

Tessellate BIO was founded to develop precision oncology approaches to treat cancers with high unmet need. We are initially focusing on validated targets to address the group of cancers that depend on the alternative lengthening of telomeres (ALT) which can be detected with our proprietary companion diagnostic.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andree Blaukat

        

Browse more venture capital transactions:

Prev: 10/17/2023: Hivebrite venture capital transaction
Next: 10/17/2023: Anonybit venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary